to identify novel compounds targeting henipavirus replication for pandemic antiviral preparedness | Pandemic PACT Tracker

Key facts

Disease
Unspecified
Start & end year
2022
Known Financial Commitments (USD)
$3,101,691
Funder
Gates Foundation
Research Location
United States of America
Lead Research Institution
University of Illinois at Chicago
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

N/A

2 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of Henipaviruses.

Discovery and Optimization of First-in-Class Furopyrimidine-based Inhibitors of Henipaviruses